Case Report: Left atrial myxoma with confirmed Delta variant COVID-19 infection, “to treat or withhold”

Abstract

Primary cardiac tumors (PCTs) are extremely rare entities. More than half of PCTs are benign, with myxoma being the most common tumor. Generally, simple tumor resection is the treatment of choice for benign PCTs since it has promising results that yield low complication and recurrence rates. However, in the COVID-19 pandemic era, the mitigation protocols and/or concurrent COVID-19 infection should be taken into account in patient management for the best overall outcome. To our knowledge, this is the first case report of a patient with a left atrial myxoma and systemic embolism complication in the form of an ischemic stroke, with a concurrent confirmed COVID-19 delta variant infection.

Case Report: an Uncommon Cause of Non-hemorrhagic Ischemic Stroke Associated with Left Atrial Myxoma

“…It has been hypothesized that it is caused by a widespread defect that causes some mesenchymal cells to proliferate too much and produce too much glycosaminoglycan. Due to (7) peripheral embolism, conduction abnormalities, intracavity or valvular obstruction, the majority of tumors are histologically benign but have a high mortality risk. The production and secretion of interleukin-6 are probably to blame for the correlation between constitutional symptoms.…”